Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Sellas Life Sciences Shares Surge 156% After Positive Leukemia Vaccine Trial Results

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Sellas Life Sciences Shares Surge 156% After Positive Leukemia Vaccine Trial Results

Analysed 18 Nov 2026·2 sources analysed·Business
Sellas Life Sciences Shares Surge 156% After Positive Leukemia Vaccine Trial ResultsPreviousNext

Shares of Sellas Life Sciences surged 156% in one day after its experimental leukemia vaccine, galinpepimut-S (GPS), showed a 41% reduction in death risk and extended median survival to 24 months in a late-stage trial involving 126 acute myeloid leukemia patients. The company plans to discuss accelerated FDA approval, targeting a 2027 filing. The stock's sharp rise added over $2.38 billion to its market value, reflecting investor optimism about the treatment's potential.

Sentiment
85%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (85/100). Lens Score 44/100.

Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 18 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (85/100)

Sentiment was consistent across outlets (85–85/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 18 Nov, 06:41 am. Other outlets followed.

18 Nov, 06:41 am2 sources · 8 h18 Nov, 02:37 pm
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
RBI Enhances Engagement with Financial Institutions to Strengthen Cybersecurity Measures
Next →
Indian-Origin Founders’ Impact and the Role of Risk in Innovation
1
economictimes18 Nov, 06:41 am
156 rally in one day! Why this drugmaker stock witnessed such skyrocketing jump on Wall Street
  • 2
    economictimes18 Nov, 02:37 pm
    156 rally in one day! Why this drugmaker stock witnessed such skyrocketing jump on Wall Street
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    United States Food and Drug Administration
    Corporate
    Sellas Life Sciences

    Story context

    Category
    Business
    Sources analysed
    2
    Last analysed
    18 Nov 2026
    Key entities
    Wall StreetExperimentVaccineAcute myeloid leukemiaGlobal Positioning SystemLeukemiaPfizer–BioNTech COVID-19 vaccineTumors of the hematopoietic and lymphoid tissuesBone marrowMarket capitalizationStockFood and Drug Administration